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Summary
 
The role of T cell receptor 
 
a
 
 enhancer (E
 
a
 
) 
 
cis
 
-acting elements in the developmental regulation
of VDJ recombination at the TCR 
 
a
 
/
 
d
 
 locus was examined in transgenic mice containing
variants of a minilocus VDJ recombination substrate. We demonstrate that the 116-bp T
 
a
 
1,2
core enhancer fragment of the 1.4-kb E
 
a
 
 is sufficient to activate the enhancer-dependent step
of minilocus rearrangement, and that within T
 
a
 
1,2, intact binding sites for TCF/LEF and Ets
family transcription factors are essential. Although minilocus rearrangement under the control
of the 1.4-kb E
 
a
 
 initiates at fetal day 16.5 and is strictly limited to 
 
ab
 
 T cells, we find that rear-
rangement under the control of T
 
a
 
1,2 initiates slightly earlier during ontogeny and occurs in
both 
 
gd
 
 and 
 
ab
 
 T cells. We conclude that the core fragment of E
 
a
 
 can establish accessibility to
the recombinase in developing thymocytes in vivo in a fashion that is dependent on the bind-
ing of TCF/LEF and Ets family transcription factors, but that these and other factors that bind
to the E
 
a
 
 core cannot account for the precise developmental onset of accessibility that is pro-
vided by the intact E
 
a
 
. Rather, our data suggests a critical role for factors that bind E
 
a
 
 outside
of the core T
 
a
 
1,2 region in establishing the precise developmental onset of TCR 
 
a
 
 rearrange-
ment in vivo.
 
O
 
rdered recombination of TCR variable (V), diversity
(D), and joining (J) gene segments is a process that is
crucial for the generation of the diverse antigen recognition
repertoires that characterize mature 
 
ab
 
 and 
 
gd
 
 T cells (1–3).
The most immature thymic population has a CD4
 
low
 
CD8
 
2
 
CD3
 
2
 
CD25
 
2
 
HSA
 
1
 
 phenotype and has all TCR
genes in unrearranged configuration (4). These cells subse-
quently lose expression of CD4 to become CD4
 
2
 
CD8
 
2
 
double negative (DN)
 
1
 
 cells, which can be further subdi-
vided into four distinct populations on the basis of CD44
and CD25 expression. DN thymocytes mature from CD44
 
hi
 
CD25
 
2
 
 to CD44
 
hi
 
CD25
 
1
 
 to CD44
 
low
 
CD25
 
1
 
 to CD44
 
low
 
CD25
 
2
 
 (5, 6). The CD44
 
low
 
CD25
 
1
 
 DN subset expresses
high levels of RAG-1 and RAG-2 and undergoes extensive
VDJ recombination at the TCR-
 
b
 
, -
 
g
 
, and -
 
d
 
 loci (7, 8).
In-frame TCR-
 
b
 
 rearrangement directs the synthesis of a
TCR-
 
b
 
 protein which, in conjunction with pT
 
a
 
, forms a
pre-TCR (9, 10) that functions to inhibit RAG-1 and
RAG-2 expression, to drive thymocyte proliferation, and to
drive thymocyte maturation through the CD44
 
low
 
CD25
 
2
 
 DN
and immature single positive (ISP) stages to the CD4
 
1
 
CD8
 
1
 
double positive (DP) stage (7, 8, 11–13). TCR-
 
a
 
 rear-
rangement is activated as thymocytes transit into the DP
stage (5, 7, 14).
The relationship between TCR gene rearrangement events
and thymocyte commitment to the 
 
ab
 
 or 
 
gd
 
 lineage has
been an area of intense interest. As TCR-
 
b
 
 and TCR-
 
g
 
rearrangements are found in both 
 
ab
 
 and 
 
gd
 
 T cells, the
initiation of rearrangement events at these loci is not associ-
ated with lineage commitment. TCR-
 
d
 
 gene segments lie
within V
 
a
 
 and J
 
a
 
 gene segments in the complex TCR-
 
a
 
/
 
d
 
locus and are therefore deleted by V
 
a
 
 to J
 
a
 
 rearrangement
(15–17). Recent reports have identified rearranged TCR-
 
d
 
genes in ISP precursors of 
 
ab
 
 T cells before the onset of
TCR-
 
a
 
 rearrangement (14) and on V
 
a
 
-J
 
a
 
 excision products
in 
 
ab
 
 thymocytes and peripheral T cells (18–20), arguing
that TCR-
 
d
 
 gene rearrangement is initiated in a common
precursor of 
 
ab
 
 and 
 
gd
 
 T cells as well. Because excised
TCR-
 
d
 
 gene VDJ recombination products are relatively
depleted of in-frame rearrangements (18, 19), it appears likely
that functional TCR-
 
d
 
 and TCR-
 
g
 
 rearrangement can
commit thymocytes towards the 
 
gd
 
 pathway and away from
the 
 
ab
 
 pathway. However, because at least some 
 
gd
 
 cells
show evidence of selection on the basis of functional TCR-
 
b
 
gene rearrangement (11), and late stage CD44
 
low
 
CD25
 
2
 
 DN
thymocytes have been shown to include precursors of both
 
ab
 
 and 
 
gd
 
 T cells (21), at least some thymocytes may re-
main uncommitted until very late in the DN population. The
activation of TCR-
 
a
 
 rearrangement as thymocytes transit
into the DP stage, with concomitant deletion of TCR-
 
d
 
,
 
1
 
Abbreviations used in this paper:
 
 DN, double negative; DP, double positive;
E
 
a
 
, 
 
a
 
 enhancer; E
 
d
 
, 
 
d
 
 enhancer; HMG, high mobility group; ISP, imma-
ture single positive.
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must irrevocably assign all remaining uncommitted thymocytes
to the 
 
ab
 
 pathway. TCR-
 
a
 
 is therefore the only TCR gene
whose rearrangement is activated in a lineage-specific fashion.
The mechanisms that establish the developmental onset of
TCR-
 
a
 
 rearrangement are therefore of particular interest. 
Numerous studies have demonstrated that transcriptional
promoters and enhancers play an important role in the de-
velopmental regulation of VDJ recombination at TCR and
Ig loci, probably by modulating accessibility of chromo-
somal recombination substrates to the recombinase ma-
chinery (for recent reviews, see references 22, 23). We
have examined the role of transcriptional enhancers in the
temporal and lineage-specific control of VDJ recombina-
tion at the TCR-
 
a
 
/
 
d
 
 locus by evaluating VDJ recombina-
tion in transgenic mice carrying variants of a human TCR-
 
d
 
gene minilocus rearrangement substrate that included either
the 1.4-kb TCR-
 
d
 
 enhancer (E
 
d
 
) or the 1.4-kb TCR-
 
a
 
enhancer (E
 
a
 
) (24, 25). We found that the developmental
regulation of minilocus rearrangement under the control of
E
 
d
 
 or E
 
a
 
 paralleled that found at the endogenous TCR-
 
a
 
/
 
d
 
locus. Specifically, in E
 
d
 
-bearing transgenic lines, the en-
hancer-dependent VD to J step of minilocus rearrangement
began on fetal day 14.5 and was equivalent in 
 
ab
 
 and 
 
gd
 
 T
cells, much like endogenous VdDdJd rearrangement. In Ea-
bearing transgenic lines, VD to J rearrangement was de-
layed until fetal day 16.5 and was limited to ab cells, much
like endogenous VaJa rearrangement (25). These results
imply that Ed and Ea play important roles in the develop-
mental regulation of VdDdJd and VaJa rearrangement, re-
spectively, at the endogenous TCR-a/d locus.
An important goal of ours has been to identify the cis-
acting elements of Ea that are critical in establishing the
precise developmental regulation of VaJa rearrangement at
the TCR-a/d locus. The core or minimal enhancer frag-
ment of Ea has been defined as a 116-bp fragment (Ta1,2)
that contains binding sites for several transcription factors,
including ATF/CREB, TCF-1/LEF-1, CBF/PEBP2, and
Ets proteins (26–28). This definition as a core or minimal
enhancer is based on the ability of Ta1,2 to potently acti-
vate plasmid reporter gene expression in transient transfec-
tion experiments and the critical role played by each of the
defined factor binding sites for significant enhancer activity.
Further supporting the role of this enhancer fragment as a
discrete functional unit is its ability to support the coopera-
tive assembly of a stable nucleoprotein complex in vitro in
the presence of the various transcription factors noted
above (28). These transcription factors and their cognate
binding sites in Ta1,2 are therefore attractive candidates for
contributing to the developmental regulation of VDJ re-
combination by Ea in vivo. Two of these binding sites
were selected for analysis in the present study. The first
binds the related TCF-1 and LEF-1 members of the high
mobility group (HMG) 21 box family of DNA binding
proteins (29–31). These proteins bind to the minor groove
of DNA and induce a sharp bend in the DNA helix that, in
the case of LEF-1, has been shown to facilitate interactions
between Ets-1 and ATF/CREB proteins bound at nonad-
jacent sites in Ta1,2 to generate a stable and active nucle-
oprotein complex (28, 32). Transient transfection experi-
ments have shown that an intact TCF-1/LEF-1 binding
site is essential for Ta1,2 enhancer activity, and that LEF-1
and TCF-1 can both transactivate reporter gene expression
by binding to Ta1,2 (28, 29, 31). The second cis-acting ele-
ment studied is the binding site for members of the Ets
family of transcription factors. Transient transfection exper-
iments have shown that an intact Ets binding site is also re-
quired for Ta1,2 enhancer activity, and that the Ets-1 pro-
tein can bind to Ta1,2 and transactivate a Ta1,2-driven
reporter gene as well (28, 33).
In the present study, we examine VDJ recombination of
the TCR d gene minilocus under the control of wild-type
Ta1,2 sequences and compare it with VDJ recombination
mediated by Ta1,2 fragments carrying mutations in either
the TCF/LEF- or Ets binding sites. Our results indicate the
Ta1,2 core enhancer can activate VDJ recombination in a
fashion that is dependent on TCF/LEF and Ets family tran-
scription factors, but that additional Ea sequences that lie
outside of the enhancer core are required for precise devel-
opmental control. 
Materials and Methods
Transgenic Mice. The Ets binding site mutation (Ta1,2mEts)
was generated by PCR using the 700-bp BstXI fragment of the
human Ea cloned into the BamHI site of pUC13 (Ea0.7) as a tem-
plate (26) (provided by J. Leiden, University of Chicago, Chicago,
IL). PCR was performed using the mutagenic oligonucleotide Ets
(TATTTTAAACTCTTCTTTCCAGAACTTGTGGCTTCT)
and the 240 primer. The PCR product was digested with DraI
and EcoRI to generate a 135-bp fragment that was ligated into
SmaI and EcoRI cut pBluescript KS1. Dideoxynucleotide se-
quence analysis of the resultant plasmid confirmed that the insert
carried a 3-bp change in the Ta1,2 Ets binding site. The 125-bp
Ta1,2mEts was excised from this plasmid by digestion with
BamHI (plus PvuI to further cleave the plasmid and prevent sub-
sequent religation), and the ends were blunted by treatment with
the Klenow fragment of Escherichia coli DNA polymerase I. The
Ta1,2mEts fragment was then ligated into XbaI-digested, blunted,
and phosphatase-treated pBluescript carrying the previously de-
scribed enhancerless minilocus (24).
Ta1,2 with a 2-bp mutation in the TCF/LEF binding site
(Ta1,2mTCF) was generated by PCR overlap extension (34) using
Ea0.7 template DNA, mutagenic oligonucleotides TCF-1A (GGG-
AGAGCTTCTATGGGTGCCCTAC) and TCF-1B (GTAGGG-
CACCCATAGAAGCTCTCCC), along with the 240 and reverse
primers. The final PCR product was digested with DraI and EcoRI,
cloned into SmaI and EcoRI cut pBluescript KS1, and sequenced.
The 125-bp Ta1,2mTCF fragment was then excised from the
plasmid with BamHI, blunt ended with Klenow, and ligated into
XbaI-digested, blunted, and phosphatase-treated pBluescript car-
rying the enhancerless minilocus.
The Ta1,2 fragment of Ea had been previously excised from
the Ea0.7 plasmid using BamHI and DraI digestion, blunt ended
with Klenow, and subcloned into EcoRV cut pBluescript KS1.
To generate a minilocus containing wild-type Ta1,2, the insert
was excised from this plasmid by digestion with HindIII and
SmaI, blunt ended with Klenow, and cloned into XbaI-digested,
blunted, and phosphatase-treated pBluescript carrying the en-
hancerless minilocus.133 Roberts et al.
After confirmation of minilocus construct structures by di-
deoxynucleotide sequence analysis, minilocus DNA was purified
as previously described (24) and microinjected into fertilized
(C57BL/6  3 SJL/J)F2 eggs by the Duke University Comprehen-
sive Cancer Center Shared Transgenic Mouse Facility. Progeny
tail DNA was initially characterized on Southern blots probed
with radiolabeled Cd and Vd1 fragments. Transgene germline
copy number was determined by analysis of Ta1,2, Ta1,2mEts,
and Ta1,2mTCF tail DNAs, along with tail DNAs of previously
identified single copy integrants, on slot blots (Schleicher & Schuell,
Keene, NH). Blots were probed with a radiolabeled Cd fragment
and the resultant hybridization signals quantified using a Betascope
(Betagen, Waltham, MA). Transgenes were maintained on a mixed
C57BL/6 3 SJL/J background.
PCR. With the exception of experiments using sorted ab
and gd cells depicted in Fig. 6, genomic DNA PCR templates
were prepared from thymi of 4-wk-old animals by standard tech-
niques (35). For single copy transgenic lines, 12 ng of genomic
DNA was used as a template for PCR reactions. For multicopy
integrants, the quantity of genomic DNA used in PCR was re-
duced to account for copy number and to insure that all PCR
signals were in the linear range. PCR templates from sorted ab
and gd thymocytes (as well as unsorted thymocytes from the same
animals) were prepared by incubation of ,1 3 106 pelleted cells
in 200 ml lysis buffer (10 mM Tris, pH 8.4, 2.5 mM MgCl2, 50
mM KCl, 200 mg/ml gelatin, 0.45% NP40, 0.45% Tween-20,
and 60 mg/ml proteinase K) for 1 h at 568C and then 15 min at
958C (36). Sample aliquots containing 5 3 103 cell equivalents
were immediately used as templates in PCR reactions. All PCR
reactions were performed identically using previously described
reaction conditions and primers (24).
Blot Hybridization of Genomic DNA and PCR Products. Gel elec-
trophoresis, blotting, and hybridization with 32P-labeled probes
were performed as previously described (24). Hybridization sig-
nals were quantified using a Betascope and reported values for
VD and VDJ rearrangement signals were normalized to the Cd
signal for each template.
Antibodies. Biotinylated H57-597 anti-TCR-b, phycoeryth-
rin-conjugated GL3 anti-TCR-gd, FITC-streptavidin, and unla-
beled 2.4G2 anti-FcgRII/III mAbs for flow cytometry were ob-
tained from PharMingen (San Diego, CA). GK1.5 anti-CD4 (37)
and 41-3.48 anti-Lyt-2.2 (38) mAbs were used for cell depletions
as culture supernatants.
Flow Cytometric Analysis and Cell Sorting. Enriched CD42CD82
cells were prepared from single cell suspensions of thymocytes
from 4-wk-old animals by treatment with saturating amounts of
GK1.5 and 41-3.48 mAbs and rabbit complement (Cedarlane
Laboratories, Ltd., Hornby, ON, Canada) for 60 min at 378C.
Viable cells were collected after centrifugation over Lympholyte-M
(Cedarlane Labs. Ltd.). The enriched CD42CD82 cells and unfrac-
tionated thymocytes from the same animal were incubated with
saturating concentrations of unlabeled 2.4G2, biotinylated H57-
597, and phycoerythrin-GL3 for 40 min at 48C in PBS with 0.1%
BSA and 0.1% NaN3, washed twice, and then stained with
FITC-Streptavidin for 20 min at 48C. Cells were subsequently
washed and sorted using a FACStar PlusÒ (Becton Dickinson,
Mountain View, CA). H57-5971 ab cells were sorted using
stained unfractionated thymocytes as a starting population while
GL31 gd cells were sorted using identically stained, enriched
CD42CD82 cells as a starting population. Immediate reanalysis of
sorted populations by two-color flow cytometry revealed con-
tamination with ,1% of cells expressing the inappropriate cell
surface TCR in all cases.
Fetal Thymus Samples. Fetal mice were obtained from timed mat-
ings of homozygous transgenic males and 6–8-wk-old (C57BL/6 3
SJL/J)F1 females (Jackson Laboratory, Bar Harbor, ME). The day
of detecting a vaginal plug was designated as day 0.5 of embry-
onic development. Genomic DNA prepared by standard tech-
niques from pooled fetal thymi of individual litters was analyzed
for minilocus rearrangement by PCR. 
Results
The 116-bp Core Ea Fragment Ta1,2 Is Sufficient to Acti-
vate Minilocus Rearrangement In Vivo. The rearrangement
substrate used in the present study has been previously de-
scribed as a 22.5-kb human TCR-d gene minilocus consist-
ing of germline Vd1, Vd2, Dd3, Jd1, Jd3, and Cd gene seg-
ments (24). Frameshift mutations within the Vd1 and Vd2
coding segments prevent the rearranged transgene from en-
coding a functional TCR polypeptide that could alter nor-
mal T cell development in transgenic mice. The initial step
of transgene rearrangement, V to D, is enhancer indepen-
dent (24). The second step of transgene rearrangement, VD
to J, is dependent on the presence of a functional enhancer
in the Jd3-Cd intron. Thus, we infer that the enhancer is re-
quired to promote J segment accessibility to the recombi-
Figure 1. Human TCR-d gene minilocus. (A) Diagram of the three
Ta1,2-containing minilocus constructs. Solid boxes, exons, open boxes, pro-
tein binding sites. Wild-type and mutant Ta2 sequences are shown. (B)
PCR products generated from Vd1 rearrangements are depicted along
with the Vd1 and Jd1 primers (arrows) used. Similar products are generated
using Vd2 and Jd1 primers. Specific PCR products are not generated from
unrearranged templates because of the large distances between primers.
The primers do not amplify products from the endogenous murine TCR-d
locus.134 Regulation of VDJ Recombination by the TCR a Enhancer
nase (24). The 1.4-kb Ea has been shown to efficiently ac-
tivate VD to J rearrangement in this system (25). To
determine whether Ta1,2, the 116-bp core fragment of
Ea, was also sufficient to activate minilocus VDJ recombi-
nation in vivo, we constructed a new TCR-d gene minilo-
cus containing this fragment in place of Ea (Fig. 1 A). Four
independent transgenic lines denoted T2, T3, T5, and T7
were established and determined by slot blot analysis to
carry 28, 1, 3, and 4 transgene copies, respectively.
VDJ recombination in the four Ta1,2 transgenic lines
was assessed by quantitative PCR of thymic genomic DNA
templates that were amplified using primers specific for
minilocus Vd1, Vd2, and Jd1 gene segments (24). PCR using
primer combinations Vd1-Jd1 or Vd2-Jd1 yields a 0.3-kb
product resulting from transgene VDJ rearrangement and a
1.2-kb fragment resulting from VD rearrangement (Fig. 1 B),
both of which can be detected on Southern blots probed
with radiolabeled Vd1- or Vd2-specific DNA fragments.
Amplification of a 0.3-kb rearrangement-independent prod-
uct with a pair of Cd primers serves as an internal control
for PCR efficiency and allows quantitative comparison of
rearrangement patterns between different templates. As
seen in Fig. 2 and Table 1, low levels of Vd1-Dd3 and high
levels of Vd1-Dd3-Jd1 rearrangement were observed in
three of four Ta1,2 lines (T2, T5, and T7). Levels of Vd1-
Dd3-Jd1 rearrangement in thymocytes from lines T2 and
T5 were 60 and 38%, respectively, of that found in thy-
mocytes from Ea line J, which includes the intact 1.4-kb Ea
(Fig. 3, Table 2). However, VD and VDJ rearranged prod-
ucts were barely detectable in Ta1,2 line T3 (Fig. 2, Table 1).
Similar variability in rearrangement phenotype among dif-
ferent lines of animals bearing an identical construct has been
noted in our previous studies (24, 39) and is likely due to
inherent differences in transgene integration sites. We sug-
gest that the minilocus is integrated into a relatively inactive
region of chromatin in line T3; in support of this notion,
preliminary in vivo footprinting studies have demonstrated
markedly diminished protection of protein binding sites
within Ta1,2 in thymus DNA of T3 mice as compared
with thymus DNA of T2, T5, or T7 mice (Hernandez-
Munain, C., personal communication). Taken as a whole,
our results demonstrate that the 116-bp Ta1,2 fragment of
Ea is, in most contexts, sufficient to mediate activation of
the enhancer-dependent VD to J step of minilocus rear-
rangement. The apparently less efficient conversion of Vd2-
Dd3 to Vd2-Dd3-Jd1 in these lines is probably related to our
previous observation that Vd2 rearrangement is only z10%
as efficient as Vd1 rearrangement in this system (24).
Ta1,2 and Ea minilocus rearrangement was also ana-
lyzed directly by genomic Southern blot (Fig. 4) as an inde-
pendent means of corroborating results obtained by quanti-
tative PCR. Analysis of Vd1 rearrangements in PstI plus
EcoRI-digested thymus DNA from Ea line L revealed low
levels of 1.0-kb germline Vd1 and 0.9-kb Vd1-Dd3 rear-
ranged fragments, and higher levels of a 1.7-kb species re-
sulting from Vd1-Dd3-Jd1 rearrangement (Fig. 4). Similar
results were obtained with Ea line J (data not shown).
Figure 2. PCR analysis of Ta1,2 and Ta1,2mTCF minilocus rear-
rangement. Genomic DNA templates from unfractionated thymocytes of
Ta1,2 mice from lines T2, T3, T5, and T7, and of Ta1,2mTCF mice
from lines JI, JJ, JK, JL, and JM (all 4 wk old) were amplifed by PCR us-
ing the indicated primers. Southern blots were probed with radiolabeled
Cd, Vd1, or Vd2 DNA fragments. The positions of 1.2-kb VD and 0.3-kb
VDJ rearrangement products are indicated.
Figure 3. PCR analysis of Ea, Ta1,2, and Ta1,2mEts minilocus rear-
rangement. Genomic DNA templates from unfractionated thymocytes of
an Ea mouse from line J, of Ta1,2 mice from lines T2 and T5, and of
Ta1,2mEts mice from lines JN, JR, and JO (all 4 wk old) were amplified
by PCR and probed as in Fig. 2.
Table 1. Minilocus Rearrangement in Thymocytes of Ta1,2
and Ta1,2mTCF Mice
Ta1,2 Ta1,2mTCF
T2 T3 T5 T7 JI JJ JK JL JM
Vd1-Dd3 0.16 0.01 0.15 0.20 0.97 2.77 1.17 0.15 0.03
Vd1-Dd3-Jd1 1.00 0.03 0.88 1.88 0.03 0.07 0.05 nd nd
Blot hybridization signals from the experiment shown in Fig. 2 were
quantified using a Betascope. Reported values are normalized to the Cd
signal for each sample. nd, not detected.135 Roberts et al.
Analysis of similarly digested thymocyte DNA from Ta1,2
line T2 also revealed levels of the fully rearranged Vd1-
Dd3-Jd1 fragment that were more prevalent than the 0.9-kb
partially rearranged (Vd1-Dd3) species (Fig. 4). Hence,
these results are consistent with those obtained by PCR
and provide confirmation that Ta1,2 alone can efficiently
activate minilocus VDJ recombination.
The conspicuous variations in total Vd1 hybridization
signal intensities seen in this experiment (Fig. 4) result in
part from differences in germline transgene copy number
between the various transgenic lines (T2 5 28, L 5 13). A
diminution of total Vd1 signal intensity in thymus DNA
relative to tail DNA isolated from the same animal is also
apparent, particularly in line T2 (Fig. 4). Slot blot quantifi-
cation revealed Cd copy number to be 13 in line L tail and
8 in L thymus, and although 28 in T2 tail, only 4 in T2
thymus (data not shown). Such copy number loss has been
noted in some other multicopy lines as well, and is likely
due to thymocyte rearrangement events between V, D, and
J gene segments within different, presumably concatameric,
copies of the minilocus, with resultant loss of intervening
sequences. These differences in thymus transgene copy num-
ber are not apparent in PCR experiments where thymus
template amounts were adjusted for Cd copy number.
An Intact TCF/LEF Binding Site Is Required for Efficient
Activation of Minilocus VD to J Rearrangement by Ta1,2.
To determine whether the activation of minilocus VDJ re-
combination by Ta1,2 in vivo is dependent on TCF/LEF
family transcription factors, a variant of the Ta1,2 minilo-
cus containing a 2-bp mutation in the TCF-1/LEF-1 bind-
ing site (Ta1,2 mTCF) was constructed (Fig. 1 A). Five
independent lines of Ta1,2mTCF transgenic mice were gen-
erated. Slot blot analysis revealed that Ta1,2mTCF lines JL
and JM each carry one copy of the minilocus, whereas lines
JI, JJ, and JK carry 5, 12, and 9 copies, respectively (data
not shown). Analysis of Ta1,2mTCF minilocus VDJ re-
combination was performed by quantitative PCR, as de-
scribed above. Notably, as assessed using both Vd1-Jd1 and
Vd2-Jd1 primer combinations, all five Ta1,2mTCF lines
displayed dramatically reduced levels of VDJ rearranged
products as compared with wild-type Ta1,2 lines T2, T5,
and T7 (Fig. 2). Quantification revealed levels of Vd1-Dd3-
Jd1 rearrangement in Ta1,2mTCF lines JI, JJ, and JK that
were only 3, 7, and 5%, respectively, of that observed in
wild-type Ta1,2 line T2 (Table 1). In lines JL and JM,
Vd1-Dd3-Jd1 rearrangement was undetectable. Because V
to D rearrangement was readily detectable in most trans-
genic lines, these results argue that mutation of the TCF/
LEF site significantly and specifically impairs the VD to J
step of minilocus VDJ recombination. Verification of these
results was obtained by genomic Southern blot analysis
which revealed an abundance of germline Vd1 and Vd1-
Dd3 rearranged fragments, but no detectable Vd1-Dd3-Jd1
rearrangement in PstI plus EcoRI digested thymus DNA
from Ta1,2mTCF line JI (Fig. 4).
The relatively low level of V to D rearrangement in
Ta1,2mTCF lines JL and JM may, in part, be a reflection
of unique properties of the transgene integration sites.
However, it is interesting that all three transgenic lines ex-
amined in this study displaying very low levels of total rear-
rangement (Ta1,2 line T3, and Ta1,2mTCF lines JL and
JM) are all single copy. This suggests an effect of copy
number as well. Nevertheless, multicopy integrants are not
required for efficient transgene VDJ recombination, as evi-
denced by the previously characterized Ed-containing lines
A, B, and C (24), and the Ta1,2mEts line JN (see below).
It may be that while a single copy transgene experiences
the full negative impact of integration into a relatively inac-
tive region of chromatin, internal copies of a concatameric
multicopy integrant might be relatively protected from
such effects.
An Intact Ets Binding Site Is also Necessary for Efficient Activation
of Minilocus VD to J Rearrangement By Ta1,2. To determine
Table 2. Minilocus Rearrangement in Thymocytes of Ea,
Ta1,2, and Ta1,2mEts Mice
Ea Ta1,2 Ta1,2mEts
JT 2 T 5 J N J R J O
V d 1-Dd3 0.30 0.15 0.19 1.09 0.77 0.99
Vd1-Dd3-Jd1 4.52 2.67 1.72 0.14 0.19 0.11
Blot hybridization signals from the experiment shown in Fig. 3 were
quantified using a Betascope. Reported values are normalized to the Cd
signal for each sample.
Figure 4. Analysis of minilocus rearrangement by genomic Southern
blot. PstI plus EcoRI-digested tail and thymus genomic DNA samples
from Ea line L, Ta1,2 line T2, Ta1,2mTCF line JI, and Ta1,2mEts line
JO mice (all 4 wk old) were analyzed by Southern blot using a radiola-
beled 1.0-kb Vd1 genomic PstI fragment. Positions of the expected 1.0-kb
germline, 0.9-kb Vd1-Dd3, and 3.2-kb Vd1-Dd3-Jd1 rearranged fragments
are indicated.136 Regulation of VDJ Recombination by the TCR a Enhancer
whether the activation of minilocus VDJ recombination by
Ta1,2 in vivo is dependent on Ets family transcription fac-
tors, a second variant of the Ta1,2 minilocus containing a
3-bp mutation in the Ta2 Ets binding site (Ta1,2mEts)
was constructed. The three independent lines of transgenic
mice generated, JN, JO, and JR, were found to carry 1, 13,
and 21 copies of the minilocus, respectively, as assessed by
slot blot analysis. VDJ rearrangement in thymocytes from
Ta1,2mEts animals was compared with that of wild-type
Ta1,2 and Ea mice by quantitative PCR. This analysis re-
vealed that the VD to J step of transgene rearrangement
was dramatically curtailed in all three lines of Ta1,2mEts
transgenic animals (Fig. 3). Specifically, the levels of Vd1-
Dd3-Jd1 rearrangement in Ta1,2mEts lines JN, JR, and JO
were only 5, 7, and 4% of that of wild-type Ta1,2 line T2
(Table 2); Vd2-Dd3-Jd1 rearrangement was only barely de-
tectable (Fig. 3). Nevertheless, VD rearrangement was high
in all three lines (Fig. 3). These results were also corrobo-
rated by genomic Southern blot of digested thymus DNA
from Ta1,2mEts line JO, which failed to reveal a discern-
ible Vd1-Dd3-Jd1 fragment despite readily detectable Vd1-
Dd3 rearrangement (Fig. 4). From these data we conclude
that the presence of an intact Ets binding site within Ta1,2
is a prerequisite for efficient activation of the VD to J step
of minilocus rearrangement in vivo.
Temporal and Lineage-specific Control of Minilocus Rearrange-
ment By Ta1,2 Is Distinct from that of Ea. The 1.4-kb Ea
has been previously shown to confer physiologically appro-
priate developmental control to the enhancer-dependent VD
to J step of minilocus rearrangement. Because the 116-bp
Ta1,2 core enhancer fragment proved sufficient to activate
minilocus rearrangement, we asked whether the core en-
hancer fragment is sufficient to impart precise developmen-
tal control as well. Accordingly, we examined the timing of
minilocus VDJ rearrangement during ontogeny in Ta1,2
transgenic animals. PCR analysis of fetal thymus genomic
DNA templates from line T2 timed pregnancies revealed
that the VD to J step of minilocus rearrangement began on
fetal day 15.5 (Fig. 5), one day earlier than that previously
noted in Ea line J (25). Identical results were obtained from
analysis of Ta1,2 line T5 (data not shown). Thus, Ta1,2
appeared to be activated slightly earlier during fetal thymic
ontogeny than the intact Ea.
We then compared minilocus VDJ recombination in
sorted  ab and gd T cell populations from adult Ta1,2 ani-
mals. As expected, PCR analyses revealed abundant VD
and VDJ rearrangement in lines T2, T5, and T7 ab thy-
mocytes (Fig. 6). Strikingly, however, gd thymocytes from
these animals also exhibited substantial VDJ rearrangement
(Fig. 6). Quantification of these data revealed that the level
of Vd1-Dd3-Jd1 rearrangement in gd cells relative to ab
cells was 8% in line T2, 65% in line T5, and 19% in line T7
(Table 3). These results cannot be explained by contamina-
tion of cell populations, since flow cytometric reanalysis
demonstrated that ,1% of the cells in the sorted popula-
tions bore the inappropriate TCR. The results from all
three lines contrast dramatically with previous observations
in Ea mice; the level of Vd1-Dd3-Jd1 rearrangement in gd cells
was negligible (2.5, 0.0, and 1.3% of the signal in ab thy-
mocytes in Ea lines J, L, and M, respectively, levels that
are probably within the limits of purity of the sorted gd
populations [25]). From these results, we conclude that trun-
cation of Ea results in partial dysregulation of VDJ recom-
bination during development. Specifically, the slightly prema-
ture activation of VDJ recombination with relaxed lineage
Figure 5. Time course of Ta1,2 minilocus rearrangement during fetal
ontogeny. Genomic DNA samples from Ta1,2 line T2 thymi isolated on
days 14.5–17.5 of gestation, as well as from a postnatal (PN) T2 mouse
(4 wk old), were amplified by PCR and probed as in Fig. 2.
Figure 6. Ta1,2 minilocus rearrangement in ab and gd thymocytes.
Genomic DNA templates from sorted ab and gd thymocytes and total un-
fractionated thymocytes (Tot.) of Ta1,2 line T2, T5, and T7 mice (4 wk
old), and a no DNA control (2) were amplified by PCR and probed as in
Fig. 2.
Table 3. Minilocus Rearrangement in ab and gd Thymocytes
of Ta1,2 Animals
T2 T5 T7
gd ab gd ab gd ab
Vd1-Dd3 1.67 0.34 2.04 0.30 1.21 0.45
Vd1-Dd3-Jd1 0.63 7.77 1.32 2.07 0.54 2.90
Blot hybridization signals from the experiment shown in Fig. 6 were
quantified using a Betascope. Reported values are normalized to the Cd
signal for each sample. Because quantification of T2, T5, and T7 sam-
ples was performed on separate blots probed at different times, the val-
ues for VD/C and VDJ/C are useful for comparison of the gd and ab
samples within a line, but are not useful for comparisons between dif-
ferent lines.137 Roberts et al.
control that is directed by Ta1,2 suggests that Ea elements
that lie outside of Ta1,2 are critical for the tightly regulated
and physiologically appropriate activation of TCR-a gene
rearrangement in vivo.
Discussion
In this study, we examined the roles of cis-acting ele-
ments of Ea in the developmental regulation of VDJ re-
combination at the TCR-a/d locus. We found that the
116-bp Ta1,2 core enhancer fragment of the 1.4-kb Ea is
sufficient to activate the enhancer-dependent VD to J step
of transgenic minilocus rearrangement, and that intact
TCF/LEF and Ets binding sites within Ta1,2 are required.
Investigation of the temporal and lineage-specific control
of VDJ recombination afforded by Ta1,2 revealed that
thymocyte VD to J rearrangement begins on fetal day 15.5
and occurs in both ab and gd cells. This contrasts with
previous results obtained in transgenic lines carrying the
1.4-kb Ea, in which VD to J rearrangement was found to
begin on fetal day 16.5 and to be limited to ab cells (25).
Taken together, these data indicate that the core fragment
of Ea can establish accessibility to the recombinase in de-
veloping thymocytes in vivo in a fashion that is dependent
on the binding of TCF/LEF and Ets family transcription
factors, but that these and other factors that bind to the Ea
core cannot account for the precise developmental onset of
accessibility that is provided by the intact Ea. Rather, our
data suggests a critical role for factors that bind Ea outside
of the core Ta1,2 region in establishing the precise devel-
opmental onset of TCR-a rearrangement in vivo.
Previous studies identified the 116-bp Ta1,2 as the core
fragment of Ea on the basis of its ability to potently activate
plasmid reporter gene expression in transient transfection
experiments, and its ability, as naked DNA, to support the
assembly of a stable multiprotein complex consisting of
ATF/CREB, LEF-1, Ets-1, and CBF/PEBP2 (26–28). Our
experiments are the first to test the core fragment of Ea in a
chromosomally integrated context. Our data indicates that
this fragment is capable of modifying chromatin structure
in vivo over a distance of at least 2 kb, as measured by its
ability to modify the accessibility of the Jd1 gene segment
to the VDJ recombinase. Furthermore, our data are the first
to provide evidence that TCF/LEF and Ets family tran-
scription factors are important regulators of Ea in a chro-
mosomal environment, suggesting that the multiprotein
complex that was previously documented to assemble in
vitro (28) may have an important role in regulating chro-
matin structure in vivo.
TCF-1 and LEF-1 are members of the HMG box family
of transcription factors that bind at the same site within
Ta1,2 (Fig. 1 A) (29–31). The roles of both of these factors
have been analyzed in vivo by targeted gene disruption.
Analysis of LEF-12/2 mice has revealed that, despite early
postnatal lethality due to impaired development of multiple
organs, TCR-a rearrangement and T cell development
proceed normally (40). TCF-12/2 animals, on the other
hand, are healthy and appear morphologically normal, but
exhibit reduced numbers of apparently normal peripheral T
cells and a significant impairment in thymocyte differentia-
tion at the transition from the ISP to DP stages of develop-
ment (41). TCR-b rearrangement appears to be unaffected
in these animals (41). However, since thymocyte TCR re-
arrangement and expression normally begins around the
ISP to DP transition that is inhibited by TCF-1 gene dis-
ruption, it is difficult to judge whether TCR-a rearrange-
ment is inhibited, albeit incompletely, as a primary conse-
quence of the mutation.
Our experiments, which tested the effects of a disrupted
TCF-1/LEF-1 binding site within Ta1,2 in a phenotypi-
cally neutral recombination reporter construct, clearly im-
plicate TCF-1, LEF-1, or related factors in the develop-
mental activation of minilocus VD to J rearrangement, and
by implication, in the developmental activation of Va to Ja
rearrangement at the endogenous TCR-a/d locus. There
are several reasons why our results may appear to contrast
with those obtained by targeted gene disruption. First, our
results may be easier to interpret unambiguously because
there is no confounding effect on T cell development cloud-
ing the interpretation of perturbed transgene rearrange-
ment. Second, our experimental approach, in which the
binding site is mutated, accounts for the possibility that
TCF-1 and LEF-1 might play important but redundant
roles in regulating TCR-a gene rearrangement. Such re-
dundancy might allow apparently normal TCR-a rear-
rangement and expression in gene targeted animals that
lack either TCF-1 or LEF-1, but not both. Third, our ex-
perimental approach would detect an effect even if a re-
lated HMG family member, rather than TCF-1 or LEF-1,
were the critical regulator of TCR-a gene rearrangement
in vivo. Finally, our test of the TCF/LEF binding site mu-
tation in the context of the Ta1,2 core enhancer, rather
than the 1.4-kb Ea, may represent a more sensitive measure
of the effect of protein binding to this site, as it eliminates
the contribution of potentially redundant cis-acting Ea ele-
ments that lie outside of Ta1,2. Such elements might mask
an effect in a TCF-1 or LEF-1 knockout, or in mutated
versions of an otherwise intact Ea. Indeed, in transient
transfection experiments, the DraI-ApaI Ea fragment con-
taining the Ta3 and Ta4 nuclear protein–binding sites can
partially compensate for deleterious mutations in Ta1,2
(27). The nature of our experiment does not allow us to
conclude that TCF/LEF family members are strictly re-
quired for the activation of TCR-a gene rearrangement
within the endogenous TCR-a/d locus in vivo. We can
reasonably conclude, however, that these factors are likely
to contribute to the developmental activation of TCR-a
gene rearrangement in vivo.
Ets transcription factors constitute a large family of DNA
binding proteins, among which, Ets-1, Ets-2, GABPa, Elf-1,
Fli-1, and Spi-B are all expressed in T cells (42, 43). Ets-1
in particular has been thought to be a regulator of Ta1,2
on the basis of its ability to transactivate gene expression in
transient transfection experiments, and its ability to interact
with ATF/CREB and CBF/PEBP2 to form a stable multi-
protein complex on Ta1,2 in vitro (28, 33). Ets-1 is prefer-138 Regulation of VDJ Recombination by the TCR a Enhancer
entially expressed in resting lymphocytes of adult mice, and
its expression in fetal and postnatal thymocytes roughly paral-
lels that of TCR-a (44, 45). Nevertheless, although gene
disruption experiments have revealed diminished numbers
of mature thymocytes and peripheral T cells with impaired
activation and survival characteristics in Ets-12/2 animals,
TCR expression appears to be normal (46, 47).
Our results, which clearly establish that an intact binding
site for Ets family members is required for efficient activation
of minilocus VD to J rearrangement by Ta1,2 in vivo, might
imply that another Ets family member is the crucial regula-
tor of Ea or compensates for the loss of Ets-1 in Ets-12/2
mice. The only other Ets-related transcription factor that is
expressed in the T lineage and whose role has been exam-
ined genetically is Fli-1. Mice expressing an altered Fli-1
allele display reduced numbers of all thymocyte subsets;
however, TCR-a rearrangement and expression was not
specifically examined (48). Fli-1 has been shown to bind to
and transactivate gene expression via Ta1,2 in transient
transfection experiments. However, the magnitude of trans-
activation was substantially less than that observed using
Ets-1, and unlike Ets-1, Fli-1 did not interact with ATF/
CREB proteins (28). Elf-1, on the other hand, has a dis-
tinct binding specificity and does not stably interact with
Ta1,2 (49). Thus, the physiologically relevant factor that
interacts with the Ta1,2 Ets site in vivo remains uncertain.
Finally, as noted above for the TCF/LEF binding site mu-
tation, our test of the Ets site mutation in the context of the
Ta1,2 rather than the 1.4-kb Ea might, due to redundancy
of cis-acting elements, detect an effect that would not be
readily detected in the Ets-1 knockout or in mutated ver-
sions of the 1.4-kb Ea. While we cannot conclude that the
binding of Ets family members is absolutely required for
the activation of TCR-a gene rearrangement within the
endogenous TCR-a/d locus, our data does implicate these
factors as potentially important contributors to the devel-
opmental activation of TCR-a gene rearrangement in
vivo.
Although our data demonstrates quite clearly that the ac-
cessibility required for the activation of VDJ recombination
can be established by the binding of TCF/LEF family, Ets
family, and presumbably other transcription factors to the
core of Ea, our data also indicates that the binding of these
factors cannot account for the precise developmental onset
of accessibility that is provided by the intact Ea. Rather, we
detect both a partial loss of lineage specificity and a partial
loss of temporal or developmental stage specificity in Ta1,2
transgenic lines. We propose that the loss of lineage speci-
ficity is a direct consequence of the loss of temporal or de-
velopmental stage specificity, as follows. Our observation
that an intact Ea activates the VD to J step of minilocus re-
arrangement exclusively in developing ab T cells implies
that the transgenic Ea is developmentally activated either
coordinately with, or subsequent to, activation of the en-
dogenous Ea, which, by inducing endogenous Va to Ja re-
arrangement, commits developing thymocytes to become
ab cells. On the other hand, the relaxed lineage specificity
of Ta1,2 implies that in at least a fraction of thymocytes,
Ta1,2 is activated before the endogenous Ea. This would
result in the activation of at least some minilocus VD to J
rearrangement in as yet uncommitted thymic precursors,
some of which would give rise to gd cells. The uncommit-
ted thymocyte population in which Ta1,2-dependent minilo-
cus VD to J rearrangement occurs is a matter of speculation,
but should be positive for RAG-1 and RAG-2. One candi-
date would be the CD44lowCD251 subset of DN cells,
which expresses high levels of RAG-1 and RAG-2, and is
actively rearranging endogenous TCR-b, -g, and -d genes
(7, 14). However, CD44lowCD252 DN and ISP thymocytes
may also be candidates if their reduced levels of RAG-1
and RAG-2 maintain permissiveness for at least low level
VDJ recombination (7, 13).
The potential for premature activation of Ea directed by
factors that interact with Ta1,2 is apparently normally held
in check by additional cis-elements of Ea. Although the
identities of the cis-elements that mediate this effect are
uncertain at present, we speculate that they might map to
the previously defined protein binding sites Ta3 and Ta4
(26, 27). Although little is known about protein binding to
these sites, it is interesting that they contain two E box mo-
tifs. Restriction of the activity of the immunoglobulin
heavy-chain enhancer to B cells has been shown to be
due, at least in part, to negative regulation involving two
E boxes, mE5 and mE4, present within the enhancer (50–52).
In addition, an E box has been implicated in the negative
regulation of CD4 gene expression during T cell develop-
ment by the CD4 transcriptional silencer (53). It is there-
fore tempting to speculate that the Ta3 and Ta4 E boxes
may play similar roles in the developmental activation of
Ea, and, as a consequence, the developmental activation of
Va to Ja rearrangement. We are currently investigating this
possibility.
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